Steve Berman (lawyer)

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Full Truck Alliance (YMM) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Monday, February 6, 2023
Research, Person, NYSE, ADS, SAN, American depositary receipt, Book, Steve Berman (lawyer), Airline, Pharmaceutical industry, YMM

The investigation focuses on Full Truck Alliance’s claims that its financial statements present fairly, in all material respects, the financial position of the company.

Key Points: 
  • The investigation focuses on Full Truck Alliance’s claims that its financial statements present fairly, in all material respects, the financial position of the company.
  • “We’re focused on investors’ losses and whether Full Truck Alliance cooked its books,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Full Truck Alliance and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Full Truck Alliance should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

TWST 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys Before Feb. 10th Deadline in Securities Class Action

Retrieved on: 
Saturday, February 4, 2023
DNA, Charles Ponzi, Person, Complaint, Public expenditure, SAN, Scorpion, Growth, Fraud, Steve Berman (lawyer), Private investigator, Pharmaceutical industry

SAN FRANCISCO, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .
  • According to the Scorpion Report, Twist is perpetuating its fraud through false reporting of capital expenditures and gross margins—which Scorpion claims are actually negative.
  • “We’re focused on investors’ losses and proving Twist lied about its technology and true financial performance,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Twist and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

FXLV 2-DAY DEADLINE ALERT: Hagens Berman Encourages F45 Training Holdings (FXLV) Investors with Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Class Action

Retrieved on: 
Saturday, February 4, 2023
NYSE, Person, SAN, IPO, News, Steve Berman (lawyer), Security (finance), Renewable energy, Pharmaceutical industry, F45

SAN FRANCISCO, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges F45 Training Holdings, Inc. (NYSE: FXLV) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges F45 Training Holdings, Inc. (NYSE: FXLV) investors who suffered significant losses to submit your losses now .
  • According to the complaint, Defendants made false and misleading statements or failed to disclose in the IPO offering documents material adverse facts about F45’s business, operations, and prospects.
  • If you invested in F45 and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding F45 should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Silvergate Capital (SI) Investors with $1M+ Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Class Action

Retrieved on: 
Saturday, February 4, 2023
FTX, Research, Person, NYSE, Sale, SI, SAN, Growth, Federal Home Loan Banks, Fraud, Steve Berman (lawyer), News, Bank, Cryptocurrency, Pharmaceutical industry, Silvergate Media

SAN FRANCISCO, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Silvergate Capital Corporation (NYSE: SI) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 04, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Silvergate Capital Corporation (NYSE: SI) investors who suffered significant losses to submit your losses now .
  • Moreover, Silvergate did not maintain sufficient liquidity to protect against a bank run.
  • Investors began to learn the truth on Nov. 7, 2022, when Silvergate suddenly and without explanation announced demotion of its Chief Risk Officer.
  • Over the ensuing months, news continued to emerge about Silvergate’s exposure to FTX and Alameda and the company’s lax compliance.

VERU 3-DAY DEADLINE ALERT: Hagens Berman Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Class Action

Retrieved on: 
Friday, February 3, 2023
Person, COVID 19, News, COVID, Patient, SAN, FDA, EUA, Steve Berman (lawyer), Pharmaceutical industry, Verus Pharmaceuticals

SAN FRANCISCO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Veru Inc. (NASDAQ: VERU) investors with significant losses to submit your losses now .
  • VERU’s filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.
  • Investors learned the truth on Nov. 9, 2022, when Veru announced that the FDA advisory committee (“AdCom”) voted against approving sabizabulin under the agency’s EUA pathway.
  • If you invested in Veru and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Evolv Technologies Holdings (EVLV) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Friday, February 3, 2023
BBC, Gun, Safety, News, Person, School, BBC News, Student, Bomb, Weapon, Steve Berman (lawyer), Research, Television, Pharmaceutical industry, Evolving digital ecological network

The investigation focuses on Evolv’s claims regarding the effectiveness of its AI-based weapons detection technology for security screening.

Key Points: 
  • The investigation focuses on Evolv’s claims regarding the effectiveness of its AI-based weapons detection technology for security screening.
  • Evolv has claimed that unlike conventional walk-through metal detectors, “our products use advanced sensors, artificial intelligence software and cloud services to reliably detect guns, improvised explosives, and large knives[.
  • “We’re focused on investors’ losses and whether Evolv may have put sales over safety and misled investors about the reliability of its technology,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Whistleblowers: Persons with non-public information regarding Evolv Technologies should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Enovix Corporation (ENVX) Investors to Filing of Securities Class Action, Encourages Investors with Significant Losses to Contact Firm’s Attorneys

Retrieved on: 
Monday, January 30, 2023
Person, Harrold, Complaint, Cybook Gen1, Silicon, SAN, Steve Berman (lawyer), Risk management, Pharmaceutical industry

SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Pending

Retrieved on: 
Monday, January 30, 2023
DNA, Charles Ponzi, Person, Complaint, Public expenditure, SAN, Scorpion, Growth, Fraud, Steve Berman (lawyer), Private investigator, Pharmaceutical industry

SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .
  • “We’re focused on investors’ losses and proving Twist lied about its technology and true financial performance,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Twist and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Twist should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Avaya Holdings Corp. (AVYA) Investors with Significant Losses to Contact Firm’s Attorneys Before Mar. 6th Deadline in Securities Class Action

Retrieved on: 
Monday, January 30, 2023
Person, NYSE, Software as a service, SAN, Audit committee, Ethics, Committee, AVYA, Steve Berman (lawyer), Audit, Pharmaceutical industry, Avaya

SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Avaya Holdings Corp. (NYSE: AVYA) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Avaya Holdings Corp. (NYSE: AVYA) investors who suffered significant losses to submit your losses now .
  • “We’re focused on investors’ losses and proving Avaya misled investors about its controls and progress of its business model transformation,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Avaya and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Avaya should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages F45 Training Holdings (FXLV) Investors with Losses to Contact Firm’s Attorneys Before Feb. 6th Deadline in Securities Class Action

Retrieved on: 
Monday, January 30, 2023
Person, IPO, News, Steve Berman (lawyer), Renewable energy, Pharmaceutical industry, F45

According to the complaint, Defendants made false and misleading statements or failed to disclose in the IPO offering documents material adverse facts about F45’s business, operations, and prospects.

Key Points: 
  • According to the complaint, Defendants made false and misleading statements or failed to disclose in the IPO offering documents material adverse facts about F45’s business, operations, and prospects.
  • This news sent the price of F45 shares crashing 61% lower on July 27, 2022.
  • If you invested in F45 and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding F45 should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.